Responses
Clinical/translational cancer immunotherapy
Original research
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
Compose a Response to This Article
Other responses
No responses have been published for this article.
